Medical Service Utilization and Direct Medical Cost of Stroke in Urban China

Dawei Zhu ¹ , Xuefeng Shi ^2,3 * , Stephen Nicholas ^4,5,6,7, Siyuan Chen ^8,1, Ruoxi Ding ⁹, Lieyu Huang ^2,3, Yong Ma ¹⁰, Ping He ¹ *

Cited by CrossRef:

1- Kazemi Z, Emamgholipour Sefiddashti S, Daroudi R, Ghorbani A, Yunesian M, Hassanvand M, Shahali Z. Estimation and predictors of direct hospitalisation expenses and in-hospital mortality for patients who had a stroke in a low-middle income country: evidence from a nationwide cross-sectional study in Iranian hospitals. BMJ Open. 2022;12(12):e067573 [Crossref]

2- Ye Q, Zhai F, Chao B, Cao L, Xu Y, Zhang P, Han H, Wang L, Xu B, Chen W, Wen C, Wang S, Wang R, Zhang L, Jiao L, Liu S, Zhu Y, Wang L. Rates of intravenous thrombolysis and endovascular therapy for acute ischaemic stroke in China between 2019 and 2020. The Lancet Regional Health - Western Pacific. 2022;21:100406 [Crossref]

3- Zhang J, Song S, Zhao Y, Ma G, Jin Y, Zheng Z. Economic burden of comorbid chronic conditions among survivors of stroke in China: 10-year longitudinal study. BMC Health Serv Res. 2021;21(1) [Crossref]

4- Huang Z, Shi X, Nicholas S, Maitland E, Yang Y, Zhao W, Ma Y, Jiang Y, Lee H. Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study. Evidence-Based Complementary and Alternative Medicine. 2021;2021:1 [Crossref]

5- Tang E, Zhou Y, Yang L, Wang N, Jiang Y, Xiao H, Hu Y, Li D, Li N, Huang Q, Du N, Li Y, Ji A, Zhou L, Cai T. The association between short-term ambient sulfur dioxide exposure and hospitalization costs of ischemic stroke: a hospital-based study in Chongqing, China. Environ Sci Pollut Res. 2022;30(7):17459 [Crossref]

6- Yan L, Huangfu C, Yang N, Li R, Yang X, Feng Y, Xuan L, Wang Q, Meng Y, Hou X, Li X. Sex- related differences in the factors associated with outcomes among patients with strokes of undetermined source: a hospital-based follow-up study. Postgraduate Medicine. 2021;133(4):428 [Crossref]

7- Kazemi Z, Emamgholipour S, Daroudi R, Yunesian M, Hassanvand M. Estimation and determinants of direct hospitalisation cost for coronary heart disease in a low-middle-income country: evidence from a nationwide study in Iranian hospitals. BMJ Open. 2024;14(8):e074711 [Crossref]

8- Li K, Huang L, Tian M, Di Tanna G, Yu J, Zhang X, Yin X, Liu Y, Hao Z, Zhou B, Feng X, Li Z, Zhang J, Sun J, Zhang Y, Zhao Y, Zhang R, Yu Y, Li N, Yan L, Labarthe D, Elliott P, Wu Y, Neal B, Lung T, Si L. Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study. Circulation. 2022;145(20):1534 [Crossref]

9- Wu Y, Han X, Qiu J. Impacts of the Zero-Markup Drug Policy on Hospitalization Expenses of Patients with Stroke in Western China: An Interrupted Time Series Analysis. RMHP. 2024;Volume 17:777 [Crossref]

10- Xie P, Li X, Guo F, Zhang D, Zhang H. Direct medical costs of ischemic heart disease in urban Southern China: a 5-year retrospective analysis of an all-payer health claims database in Guangzhou City. Front Public Health. 2023;11 [Crossref]

11- Fang Q, Shang D, Zhang Y, Geng X, Liu F, Zhang Q, Wang X. Will the zero-margin drug policy reduce the economic burden of stroke patients in China?. J Glob Health. 2021;11 [Crossref]

12- Yang Y, Nicholas S, Maitland E, Huang Z, Chen X, Ma Y, Shi X. An equity evaluation in stroke inpatients in regard to medical costs in China: a nationwide study. BMC Health Serv Res. 2021;21(1) [Crossref]

13- Zhang W, Zhou W, Ye M, Gao Y, Zhou L. Family resilience of stroke survivors within 6 months after a first-episode stroke: A longitudinal study. Front Psychiatry. 2022;13 [Crossref]

14- Xu T, Loban E, Wei X, Zhou Z, Wang W. Comparison of Health Care Utilization in Different Usual Sources of Care Among Older People With Cardiovascular Disease in China: Evidence From the Study on Global Ageing and Adult Health. Int J Public Health. 2024;68 [Crossref]

15- Yang Y, Nicholas S, Li S, Huang Z, Chen X, Ma Y, Shi X. Health care utilization for patients with stroke: a 3-year cross-sectional study of China’s two urban health insurance schemes across four cities. BMC Public Health. 2021;21(1) [Crossref]

16- Zhao Y, Su B, Zhu D, Guan X, Ding R, Guo D, Lu F, He P. Medical service utilization and costs of autism spectrum disorder: Evidence from hospital records in Beijing, China. Autism Research. 2023;16(7):1462 [Crossref]

17- Zhang Z, Bao Y, Gu Y, Zhang M, Li X. Cost‐effectiveness analysis of CYP2C19 genotype‐guided antiplatelet therapy for patients with acute minor ischemic stroke and high‐risk transient ischemic attack in China. Brit J Clinical Pharma. 2024;90(2):483 [Crossref]

Submit Your Paper Archive